Prosigna is powered by the best-in-class nCounter® Analysis System
Now, local qualified laboratories can generate precise gene expression profiling1.
- Strong analytical performance: sensitive, precise, and quantitative
- Single-tube multiplexing: all 50 Prosigna genes are measured in a single reaction – no amplification required
- Easy to use, fully automated, intuitive user interface
References: 1. Prosigna [Package Insert]. Seattle, WA: NanoString Technologies, Inc; 2013.
The only breast cancer genomic assay FDA cleared for FFPE tissue
Convenience without compromise
Reference: Prosigna [Package Insert]. Seattle, WA: NanoString Technologies, Inc; 2013.